Skip to content

Revolution Medicines, Inc. RVMD Payment-in-kind interest

Payment-in-kind interest at other companies

Global Payments logo
Global PaymentsGPN
$16.34M-16.2%
NexPoint Real Estate Finance logo
NexPoint Real Estate FinanceNREF
$25.7M+693%
VICI Properties Inc. logo
VICI Properties Inc.VICI
$13.54M
Blackstone Mortgage Trust logo
Blackstone Mortgage TrustBXMT
$5.11M+43.0%
KKR Real Estate Finance Trust logo
KKR Real Estate Finance TrustKREF
$0-100%
Apollo Commercial Real Estate Finance logo
Apollo Commercial Real Estate FinanceARI
$9.78M

Other financials

Income statement

See full
Revenue-
Operating income-$445.2M-84.9%
Net income-$453.8M-113%
EPS (diluted)-$2.29-103%

Balance sheet

See full
Cash & equivalents$440.9M+32.2%
Total debt$156.6M+16.6%
Total equity$1.5B-27.8%
Total assets$2.3B-4.7%

Cash flow

See full
Operating cash flow-$354.2M-82.2%
CapEx$1.5M-52.9%
Free cash flow-$355.7M-79.9%

Valuation

See full
Market cap$34.65B+193%
Enterprise value$34.37B+198%

Profitability

See full
Operating margin-88,031.9%-89,488pp
Net margin-76,423.3%-77,733pp

Returns & leverage

See full
Return on equity-76.7%-923pp
Debt / equity0.1×0.0×
Current ratio6.8×-6.7×

Where this comes from

Reported directly by Revolution Medicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaidInKindInterest.

The official record: Revolution Medicines, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Revolution Medicines, Inc.'s payment-in-kind interest.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Revolution Medicines, Inc.'s payment-in-kind interest?
Revolution Medicines, Inc. (RVMD) reported payment-in-kind interest of $12.2M in Q1 2026.
What does payment-in-kind interest mean?
Interest expenses that are paid with additional debt or equity instead of cash.
How do you interpret payment-in-kind interest?
High PIK interest suggests a company is conserving cash but increasing its long-term debt burden.
How does payment-in-kind interest compare across companies?
Used by companies managing cash burn during high-growth or clinical-stage phases.